Compound Monograph
8-Deoxylactucin
8-Deoxylactucin is a bitter guaianolide sesquiterpene lactone of chicory root — repeatedly the compound that bio-guided fractionation converges on for chicory's anti-inflammatory and anthelmintic activity, and a breeding target for de-bittering chicory. Despite a common worklist attribution, it is not a documented wild-lettuce compound.
Sources · 4
Where Does It Come From?
8-Deoxylactucin is a naturally occurring sesquiterpene lactone (guaianolide), found in Chicory, Cichorium bottae, Garden lettuce and 1 other source. It is well tolerated orally (low toxicity).
Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
8-Deoxylactucin at a Glance
8-Deoxylactucin is a bitter guaianolide sesquiterpene lactone — one of the three principal lactones of chicory (Cichorium intybus) root, alongside lactucin and lactucopicrin. Structurally it is lactucin minus a single oxygen: the C-8 hydroxyl is absent, which is the whole of the difference and the reason for the name.
Its interest is unusual for a minor plant lactone. Across four independent research groups working on completely different endpoints — COX-2 suppression, nitric-oxide production, nematode paralysis, and a full anti-inflammatory structure–activity screen — bio-guided fractionation of chicory has repeatedly converged on 8-deoxylactucin as the most active compound in the extract 2,
It has a second life as an agricultural nuisance. Chicory is grown industrially for inulin, and these lactones are the reason the root tastes bitter; a substantial breeding and gene-editing literature exists on turning their production up or down 11,
There is no human data of any kind on the isolated compound, and — as the next section sets out — it is not a wild-lettuce molecule.
Is It Actually a Wild-Lettuce Compound?
This page was commissioned from a wild-lettuce (Lactuca virosa) research note. The attribution does not survive checking, and the honest answer is that 8-deoxylactucin is a chicory compound.
The check is simple enough to reproduce. As of 31 July 2026, PubMed returns 26 records for deoxylactucin and 21 records for "Lactuca virosa". The two sets do not intersect at a single record, and the direct query deoxylactucin AND virosa returns zero. Every paper in which the isolated molecule is assayed uses Cichorium intybus, Cichorium bottae, or Lactuca sativa — never L. virosa.
The likely origin of the mix-up is visible in the literature itself. The one study that frames these guaianolides as wild-lettuce compounds — Wesołowska and colleagues’ mouse analgesia work — describes its test compounds as “characteristic bitter sesquiterpene lactones of Lactuca virosa and Cichorium intybus” 19Reference 19AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in miceView study →. But the three compounds it actually tested were lactucin, lactucopicrin and 11β,13-dihydrolactucin. 8-Deoxylactucin was not among them. It appears to have been absorbed into the wild-lettuce story by association with its better-studied siblings, which genuinely are shared between the two plants.
Two further cautions belong here, because this is exactly the kind of compound that attracts silent contamination:
- The genus is not the species. Deoxylactucin-type conjugates are documented from Lactuca latex — Sessa and colleagues profiled L. sativa cv. Diana and other Lactuca species and found oxalate and sulfate conjugates of lactucin, deoxylactucin and lactucopicrin 16Reference 16Metabolite profiling of sesquiterpene lactones from Lactuca speciesView study →. So the compound class is real in lettuce. That is not the same as a primary report placing 8-deoxylactucin in L. virosa, which the indexed record does not contain. A trace presence in wild lettuce is plausible; it is simply undocumented.
- The sulfate-conjugate names are not interchangeable. The lettuce literature reports both a 15-deoxylactucin-8-sulfate and an 8-deoxylactucin-15-sulfate 15,
16Reference 15Perception of bitterness, sweetness and liking of different genotypes of lettuceView study →Reference 16Metabolite profiling of sesquiterpene lactones from Lactuca speciesView study → . These cannot both be conjugates of the molecule here: 8-deoxylactucin has no oxygen at C-8 at all (its systematic name retains only the C-15 hydroxymethyl), so no 8-sulfate ester of it can exist. At least one of those names refers to a different isomer. Any figure quoted for a “deoxylactucin sulfate” in lettuce should be traced to its structure before it is attached to this compound.
Nothing else here is a wild-lettuce finding. Where wild lettuce is relevant, it is as the plant that does contain lactucin and lactucopicrin — see wild lettuce.
The α-Methylene-γ-Lactone Question
Most sesquiterpene lactones owe their reactivity to an exocyclic α-methylene group on the lactone ring, a Michael acceptor that alkylates cysteine thiols. Because that warhead hits NF-κB, iNOS, and a long list of other thiol-dependent targets, “inhibits NF-κB in vitro” is close to uninformative about any individual member of the class. So the first question about any sesquiterpene lactone is whether it has the group at all — several well-known ones do not.
8-Deoxylactucin does have it. Its structure carries the exocyclic methylene on the γ-lactone (systematic name: 3-methylidene-..-azuleno[4,5-b]furan-2,7-dione; C₁₅H₁₆O₄, MW 260.28), exactly as lactucin (C₁₅H₁₆O₅) does — the two differ only by the C-8 hydroxyl. The 11β,13-dihydro derivatives that also occur in chicory are the ones with the methylene saturated away 6,
So the default reading applies: most of what 8-deoxylactucin does in a cell is class reactivity, not a private property. Its NF-κB suppression, its iNOS and COX-2 effects, and its cytotoxicity toward parasites are all things a competent Michael acceptor does.
What is genuinely specific to this molecule is narrower, and more interesting: it consistently outperforms its own near-identical siblings. Lactucin and lactucopicrin carry the same warhead and co-occur in the same tissue, yet four unrelated groups found 8-deoxylactucin the stronger of them:
| Study | Endpoint | Result |
|---|---|---|
| Zhou 2025 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study → | Anti-inflammatory screen of 18 chicory lactones | 8-deoxylactucin the most potent component |
| Harmatha 2024 9Reference 9Inhibitory effect of selected guaianolide and germacranolide sesquiterpene lactones on nitric oxide productionView study → | Nitric-oxide production, mouse peritoneal cells | 8-deoxylactucin “the apparently most active substance” |
| Valente 2021 5Reference 5Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionationView study → | Anthelmintic bio-guided fractionation | 8-DOL “most strongly associated with anti-parasitic activity” |
| Foster 2011 7Reference 7In vitroIn vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg populationView study → | Haemonchus contortus egg hatch | DOL-rich extract EC₅₀ 2.6 mg/mL vs lactucin-rich 6.4 mg/mL; “LAC has minimal effect” |
A reasonable hypothesis is that removing the C-8 hydroxyl raises lipophilicity and membrane access without touching the warhead — but that is a hypothesis. No one has tested it directly, and the one endpoint where the ranking reverses is acetylcholinesterase, where lactucopicrin is twice as potent 1Reference 1Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybusView study →. The ordering is target-dependent, and should not be generalised into “8-deoxylactucin is the strong one.”
What It's Used For
All of it is preclinical. The anti-inflammatory work is the only strand with an animal result for the isolate; everything else is in vitro or extract-level.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Nothing here rises above preclinical, so read the ceilings rather than the ranks.
The strongest strand, and the only one with a whole-animal result for the pure compound. In a screen of 3 new and 15 known sesquiterpene lactones from Cichorium intybus, 8-deoxylactucin was identified as the most potent anti-inflammatory component in LPS-stimulated RAW264.7 macrophages, cutting nitric oxide and suppressing IL-1β, IL-6 and TNF-α; mechanistically it blocked IKKα/β and IκBα phosphorylation while enhancing NRF2 expression and nuclear translocation, and in mice it reduced markers of LPS/D-galactosamine-induced acute hepatitis 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study →.
Independent support comes from Cichorium bottae root, where among 12 isolates it inhibited iNOS at IC₅₀ 6.8 ± 0.1 µM — the most potent compound in that paper by a factor of three 3Reference 3Phytochemical analysis of Cichorium bottae root and anti-inflammatory potential assessment of isolatesView study →; from mouse peritoneal cells, where it was “the apparently most active substance” for nitric-oxide inhibition among a guaianolide/germacranolide panel 9Reference 9Inhibitory effect of selected guaianolide and germacranolide sesquiterpene lactones on nitric oxide productionView study →; and from the earlier finding that it is the key inhibitor of COX-2 protein expression in chicory root extract acting on TNF-α-stimulated HT29 cells 4Reference 4Inhibition of the expression and activity of cyclooxygenase-2 by chicory extractView study →.
A supercritical-CO₂ chicory fraction containing it inhibited an inflammatory reporter gene by 53.4 ± 3.9% at 10 µg/mL 10Reference 10Supercritical CO₂ extraction as a tool to isolate anti-inflammatory sesquiterpene lactones from Cichorium intybus L. rootsView study →.
Isolate throughout, except the scCO₂ fraction, which is extract-level.
Gap: one animal model, one dose regimen, no dose–response curve, no comparator drug, and no replication of the in-vivo hepatoprotective result by a second group. The dual NF-κB-down/NRF2-up mechanism is exactly what a thiol-alkylating Michael acceptor produces, so it does not distinguish this molecule from the class — only the potency ranking within the class does.
Forage chicory is used as a bioactive pasture crop for grazing livestock, which is why this literature exists at all. Molecular networking and bio-guided fractionation across five chicory cultivars, assayed against Ascaris suum, identified sesquiterpene lactones as the active group and 8-DOL as “the compound most strongly associated with anti-parasitic activity”, with activity also confirmed against Teladorsagia circumcincta and Cooperia oncophora; critically, the same paper concluded it “acts in a synergistic combination with other SL” rather than independently 5Reference 5Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionationView study →.
Against Haemonchus contortus eggs, a DOL-dominant Puna extract inhibited hatching at EC₅₀ 2.6 mg/mL versus 6.4 mg/mL for a lactucin-dominant extract (P<0.0001), with the authors noting “LAC has minimal effect” 7Reference 7In vitroIn vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg populationView study →.
In Ostertagia ostertagi assays, the cultivar extract richer in 11,13-dihydro-8-deoxylactucin was significantly more potent in larval-feeding and adult-motility assays, though electron microscopy found no cuticular damage 6Reference 6In vitroSesquiterpene lactone containing extracts from two cultivars of forage chicory (Cichorium intybus) show distinctive chemical profiles and in vitro activity against Ostertagia ostertagiView study →.
Gap: every potency figure belongs to a whole extract, quantified by its lactone content — no EC₅₀ has been published for purified 8-deoxylactucin against any nematode. The synergy finding 5Reference 5Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionationView study → means the isolate may well underperform the extract. No in-vivo anthelmintic study of the pure compound exists in any host.
The claim that brought this compound onto the worklist, and it needs deflating rather than repeating. An “in combo” virtual-plus-wet screen of Cichorium intybus root identified two non-alkaloid acetylcholinesterase inhibitors: 8-deoxylactucin at IC₅₀ 308.1 µM (CI₉₅ 243.9–405.3) and lactucopicrin at IC₅₀ 150.3 µM (CI₉₅ 100.8–188.1); the parent dichloromethane extract gave 70% inhibition at 1 mg/mL 1Reference 1Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybusView study →.
Both figures are hundreds of micromolar — three to four orders of magnitude weaker than the cholinesterase inhibitors used clinically, and far above any plausible tissue concentration from eating chicory. Note also the direction: on this target 8-deoxylactucin is the weaker of the two compounds, the reverse of the anti-inflammatory ranking. Isolate, in vitro, single paper, never replicated.
Gap: no cell-based or animal cognition model, no blood-brain-barrier data, no selectivity testing against butyrylcholinesterase, and no replication in twenty years. Describing 8-deoxylactucin as “an acetylcholinesterase inhibitor” without the 308 µM attached overstates it substantially.
The thinnest strand. Chicory root extracts inhibited growth of zoophilic and anthropophilic dermatophytes and produced morphological anomalies in the fungal cells, with the authors attributing the activity to the presence of “the two main sesquiterpene lactones, 8-deoxylactucin and 11β,13-dihydrolactucin” 8Reference 8Chicory extracts from Cichorium intybus L. as potential antifungalsView study →.
That is an attribution by correlation with extract composition, not a bioassay of the purified molecule. Extract-level, not isolate.
Gap: no MIC for the pure compound against any fungus, no comparison with a standard antifungal, no mechanism beyond microscopy, and no work since 2005.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| α-Methylene-γ-lactone / cysteine thiols | Michael-acceptor alkylation — the class mechanism underlying most of the activity below; required for the anti-inflammatory effect across the chicory series 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study → | all in-vitro activity (classnot compound-specific) |
| IKKα/β → IκBα phosphorylation → NF-κB | Blocked, suppressing IL-1β, IL-6, TNF-α transcription 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study → | anti-inflammatory / hepatoprotective |
| NRF2 | Expression and nuclear translocation enhanced — the cytoprotective arm, and the likely basis of the liver result 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study → | hepatoprotective |
| iNOS / nitric-oxide production | Inhibited; IC₅₀ 6.8 ± 0.1 µM in the C. bottae isolate panel 3Reference 3Phytochemical analysis of Cichorium bottae root and anti-inflammatory potential assessment of isolatesView study →; most active of a guaianolide/germacranolide panel in mouse peritoneal cells 9Reference 9Inhibitory effect of selected guaianolide and germacranolide sesquiterpene lactones on nitric oxide productionView study → | anti-inflammatory |
| COX-2 protein expression | Identified as the key inhibitor in chicory root extract, via NF-κB, with additional direct COX-2-selective enzyme inhibition by the extract 4Reference 4Inhibition of the expression and activity of cyclooxygenase-2 by chicory extractView study → | anti-inflammatory |
| Acetylcholinesterase | Weak inhibition, IC₅₀ 308.1 µM — weaker than lactucopicrin’s 150.3 µM 1Reference 1Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybusView study → | the cognition claim (and its ceiling) |
| Nematode viability (A. suum, H. contortus, O. ostertagi, C. oncophora) | Larval feeding, exsheathment, motility and egg-hatch inhibition; synergistic with co-occurring lactones, no cuticular damage 5, | anthelmintic |
| (+)-Germacrene A synthase → kauniolide synthase → lactucin synthase (CYP71DD33) | The biosynthetic route in chicory; knocking out the last step diverts flux into 8-deoxylactucin 11, | plant biosynthesis / breeding |
The load-bearing caveat: rows 1–5 are what any α-methylene sesquiterpene lactone does. The compound-specific finding is that 8-deoxylactucin sits at the potent end of its own structural series on inflammation and parasites, and at the weak end on cholinesterase.
Pharmacokinetics
There is no pharmacokinetic study of 8-deoxylactucin in any species. No absorption, oral bioavailability, Cmax, volume of distribution, protein binding, half-life, or CYP profile has been measured, and no validated bioanalytical method for it in plasma has been published. That absence is the page’s binding constraint: the anti-inflammatory figures are single-digit micromolar and the cholinesterase figure is 308 µM, and nothing establishes that either concentration is reachable in a human.
What does exist is gut-microbiota metabolism data for the class, which is directly relevant and mostly bad news for the parent compound. In vitro faecal fermentation and a human feeding study showed dietary sesquiterpene lactones from lettuce and escarole are extensively catabolised by gut bacteria, chiefly by dehydroxylation and double-bond hydrogenation; deoxylactucin was detected as one of the products of lactucopicrin metabolism, and phase-II glucuronide and sulfate conjugates of deoxylactucin and related metabolites appeared in volunteers’ urine with “large inter-subject variability” 17Reference 17In vitroHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivoView study →. Two consequences follow. First, the double-bond hydrogenation reported there is precisely the reaction that would destroy the α-methylene warhead, converting the compound to its inactive dihydro form. Second, 8-deoxylactucin is not only an intake but a metabolite — a mouse study found faecal 8-deoxylactucin rose after probiotic administration 21Reference 21AnimalBacteroides salyersiae is a candidate probiotic species with potential anti-colitis properties in the human colon: first evidence from an in vivo mouse modelView study → — so its concentration in the gut is partly a microbiome variable rather than a dose variable.
Clinical Trials
None. 8-Deoxylactucin has never been administered to humans as an isolated compound, and no registered trial has studied it. There is no standardised chicory preparation that specifies its content — commercial chicory breeding runs in the opposite direction, selecting for less of it 13Reference 13Silencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus LView study →.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| — | — | — | Anti-inflammatory (isolate, mouse); anthelmintic (in vitro); AChE (in vitro); antifungal (extract) |
Last checked: July 2026.
Isolate vs. Plant Studies
This molecule sits in an unusually clean position on the isolate question, and it is worth stating precisely because the surrounding literature is full of whole-extract claims.
The anti-inflammatory strand is genuine isolate work. The compound was purified and assayed as a single substance in all four supporting papers, and the mouse hepatitis experiment dosed the isolate 2,
The anthelmintic strand is not. Despite being framed as compound identification, every potency number belongs to a cultivar extract characterised by its lactone profile 6,
The antifungal strand is extract-only 8Reference 8Chicory extracts from Cichorium intybus L. as potential antifungalsView study →, and the acetylcholinesterase result, while isolate-based, is a single unreplicated in-vitro screen at a concentration with no physiological meaning 1Reference 1Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybusView study →.
Two further disciplines matter for this compound specifically. Species discipline: the pharmacology is chicory pharmacology, and importing it into a wild-lettuce context is the error to correct — see above. Sibling discipline: 8-deoxylactucin, lactucin and lactucopicrin are almost always reported as a set, and their numbers are easily transposed. The figures here belong to 8-deoxylactucin alone; where a comparison is made, the sibling’s figure is given alongside it.
Finally, one published result has been withdrawn. A 2019 paper reporting antitumour effects of 8-deoxylactucin in RB355 retinoblastoma cells was retracted in 2021 for non-original and manipulated figures 23Reference 23Retracted: antitumor effects of 8-deoxylactucin in RB355 human retinoblastoma cells are mediated via apoptosis induction, reactive oxygen species production, and cell cycle arrestView study →. It is excluded from the evidence above and should not be cited.
Bitterness & The Chicory Breeding Problem
Chicory’s economic value is inulin, a dietary fibre and sugar substitute extracted from the taproot — and 8-deoxylactucin is one of the reasons that root tastes bitter. The compound therefore has a substantial applied-genetics literature written from the perspective of wanting less of it.
In the root the lactones are mostly not free: NMR profiling of sugarloaf chicory confirmed that the major root lactones — lactucin, 8-deoxylactucin and lactucopicrin — occur as 15-oxalate conjugates, which are markedly more water-soluble than the parent compounds and therefore follow the inulin into the extract 20Reference 20Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigationView study →. The same study found all three conjugates fell by 39–50% under reduced irrigation, so bitterness is also an environmental variable, not only a genetic one 20Reference 20Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigationView study →.
The genetic work has run in both directions, and it is the clearest demonstration of where this molecule sits in the pathway:
- Silencing germacrene A synthase (CiGASlo/CiGASsh), the committed first step, reduces guaianolide oxalate content overall — the blunt approach to de-bittering 13Reference 13Silencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus LView study →.
- Knocking out kauniolide synthase by CRISPR/Cas9 blocks the pathway further downstream, causing costunolide and its conjugates to pile up in the taproot instead 12Reference 12CRISPR/Cas9 targeted inactivation of the kauniolide synthase in chicory results in accumulation of costunolide and its conjugates in taprootsView study →.
- Knocking out lactucin synthase (CYP71DD33) does the opposite of de-bittering and is the most informative result here: because that enzyme hydroxylates C-8 to make lactucin, removing it diverts flux into 8-deoxylactucin and its derivatives, which accumulate strongly 11Reference 11Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.)View study →. The paper’s framing is telling — it treats the enriched 8-deoxylactucin lines as a route to an anti-inflammatory product, not a flavour problem.
For flavour research the relevant conjugate is a sulfate rather than an oxalate: in a lettuce sensory-genetics study, 8-deoxylactucin-15-sulphate was among the compounds contributing most to perceived bitterness across genotypes, with the bitter-to-sweet compound ratio the key determinant of both bitterness and liking 15Reference 15Perception of bitterness, sweetness and liking of different genotypes of lettuceView study →. (See the naming caution in the attribution section above before transferring that figure to the free lactone.)
Prevalence in Nature
8-Deoxylactucin is a Cichorieae compound — the chicory/lettuce tribe of the Asteraceae — and is not reported broadly outside it.
Its principal documented source is the root of chicory (Cichorium intybus), where it is one of the three main bitter guaianolides alongside lactucin and lactucopicrin; leaves contain them too, but the roots are described as carrying the high concentrations 14Reference 14de Kraker JW, Franssen MC, de Groot A, König WA, Bouwmeester HJ (1998). (+)-Germacrene A biosynthesis. The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiology. https://pubmed.ncbi.nlm.nih.gov/9701594/View study →. It occurs there predominantly as the 15-oxalate conjugate 20Reference 20Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigationView study →. A second Cichorium species, C. bottae, yields it from the root as well 3Reference 3Phytochemical analysis of Cichorium bottae root and anti-inflammatory potential assessment of isolatesView study →. Within Lactuca, deoxylactucin-type oxalate and sulfate conjugates are documented from the latex of garden lettuce (Lactuca sativa) and other Lactuca species 16Reference 16Metabolite profiling of sesquiterpene lactones from Lactuca speciesView study →, and 8-deoxylactucin-15-sulphate is a bitterness contributor across lettuce genotypes 15Reference 15Perception of bitterness, sweetness and liking of different genotypes of lettuceView study → — but, as set out above, wild lettuce (L. virosa) is not a documented source.
Quantitatively the record is poor. No absolute concentration for 8-deoxylactucin in field-grown chicory root has been located in a form usable for comparison — the recent profiling work reports relative changes rather than mg/g 20Reference 20Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigationView study →, and the anthelmintic literature reports whole-extract lactone content rather than compound concentration 6,
Content is also not stable: drought cut the root lactone conjugates by 39–50% in one cultivar 20Reference 20Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigationView study →, and cultivar differences in the forage-chicory literature are large enough that Puna and Forage Feast are treated as chemically distinct chemotypes, one DOL-dominant and one lactucin-dominant 7Reference 7In vitroIn vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg populationView study →.
Discovery & Synthesis
First isolation is not well documented. No primary isolation report for 8-deoxylactucin is retrievable in the indexed literature; the compound entered the record as one of a cluster of chicory bitter principles characterised alongside lactucin and lactucopicrin, and by 1998 it was being described without introduction as one of the “bitter sesquiterpene lactones such as the guaianolides lactupicrin, lactucin, and 8-deoxylactucin” found in chicory leaves and roots 14Reference 14de Kraker JW, Franssen MC, de Groot A, König WA, Bouwmeester HJ (1998). (+)-Germacrene A biosynthesis. The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiology. https://pubmed.ncbi.nlm.nih.gov/9701594/View study →. The name is purely descriptive: it is lactucin lacking the oxygen at C-8.
Biosynthesis is, by contrast, unusually well mapped — chicory has served as the model system for guaianolide biosynthesis. The committed step is the cyclisation of farnesyl diphosphate to (+)-germacrene A by germacrene A synthase, isolated from chicory roots in 1998, which confirmed the mevalonate → farnesyl diphosphate → germacradiene route 14Reference 14de Kraker JW, Franssen MC, de Groot A, König WA, Bouwmeester HJ (1998). (+)-Germacrene A biosynthesis. The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiology. https://pubmed.ncbi.nlm.nih.gov/9701594/View study →. Downstream, kauniolide synthase forms the guaianolide skeleton 12Reference 12CRISPR/Cas9 targeted inactivation of the kauniolide synthase in chicory results in accumulation of costunolide and its conjugates in taprootsView study →, and lactucin synthase (CYP71DD33) performs the C-8 hydroxylation that converts 8-deoxylactucin into lactucin 11Reference 11Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.)View study →. That last enzyme places this molecule precisely: 8-deoxylactucin is the direct biosynthetic precursor of lactucin, which is why disabling the enzyme causes it to accumulate 11Reference 11Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.)View study →.
No total synthesis of 8-deoxylactucin is documented, and none would be commercially motivated. Production today is by extraction from chicory root — supercritical CO₂ extraction has been developed specifically to recover the anti-inflammatory lactone fraction 10Reference 10Supercritical CO₂ extraction as a tool to isolate anti-inflammatory sesquiterpene lactones from Cichorium intybus L. rootsView study → — or by biotechnological routes: hairy-root culture accumulates the glucoside to 1.4% dry weight 18Reference 18Long-term cultured hairy roots of chicory — a rich source of hydroxycinnamates and 8-deoxylactucin glucosideView study →, and CRISPR lactucin-synthase knockout lines were built expressly to enrich the taproot in this compound 11Reference 11Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.)View study →. There is no commercial supply of it as a nutraceutical ingredient.
Patents: not yet researched.
Toxicity & Safety
8-Deoxylactucin carries a low flag, with the emphasis on how little is known rather than on demonstrated safety. It occurs in chicory and lettuce, both eaten routinely, and no toxicity signal has emerged from that dietary exposure. But the isolated compound has never been given to a human, and no toxicology package exists for it — no acute or repeat-dose study, no genotoxicity assay, no reproductive study, in any species. Low here means unremarkable-in-food, not characterised-and-cleared.
Two structural cautions are worth stating explicitly.
It is a Michael acceptor. The α-methylene-γ-lactone that drives the pharmacology alkylates cysteine thiols indiscriminately, which is the mechanism behind sesquiterpene-lactone contact allergy and behind the cytotoxicity of the more aggressive members of the class. 8-Deoxylactucin has not been implicated in harm at dietary levels, but the reactive group is present and the concentrated compound should not be assumed benign on the strength of chicory being a salad vegetable.
Asteraceae contact dermatitis applies at the class level. Sesquiterpene lactones are the principal allergens of the daisy family, and chicory and lettuce sit within it. One point of testing practice matters here and is frequently misread: the standard sesquiterpene-lactone patch-test mix contains only alantolactone, costunolide and dehydrocostus lactone 22Reference 22Sensitization and cross-reaction patterns in Danish Compositae-allergic patientsView study →. 8-Deoxylactucin is not in it. A negative SL-mix patch test therefore excludes nothing about sensitisation to this compound — and the same study noted that most lettuce-sensitised patients were picked up by the Compositae mix rather than the SL mix, and that 19% of occupationally sensitised patients were negative to both, “making very aimed patch testing necessary” 22Reference 22Sensitization and cross-reaction patterns in Danish Compositae-allergic patientsView study →.
Interactions have not been assessed. No CYP inhibition or induction data, no transporter (P-gp) data, and no drug-interaction study of any kind exists for this molecule. The gut-microbiota finding that the class is extensively catabolised and conjugated with large inter-individual variation 17Reference 17In vitroHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivoView study → means exposure would be unpredictable even if a dose were defined.
- Dietary exposure is routine and unremarkable. Present in chicory and lettuce, both widely eaten, with no toxicity signal from food use.
- Reactive α-methylene-γ-lactone. A cysteine-thiol alkylator; the concentrated isolate should not inherit the safety record of the salad vegetable.
- Asteraceae contact allergy is a class risk, and the standard SL-mix patch test does not contain this compound — a negative mix result excludes nothing here 22Reference 22Sensitization and cross-reaction patterns in Danish Compositae-allergic patientsView study →.
- No toxicology of any kind for the isolate. No acute, repeat-dose, genotoxicity or reproductive study in any species; no human exposure.
- No interaction data. No CYP, transporter or drug-interaction work; gut-microbial metabolism of the class is extensive and highly variable between people 17Reference 17In vitroHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivoView study →.
Dosage
There is no dose. 8-Deoxylactucin has never been administered to a person as an isolated compound, no clinical trial has studied it, and no chicory or lettuce product is standardised to its content. Commercial chicory breeding actively selects against it, because in an inulin crop it is a bitterness defect rather than a desired active 13Reference 13Silencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus LView study →.
The figures that exist are research concentrations and animal doses, listed only so they are not mistaken for human guidance:
| Context | Model | Figure |
|---|---|---|
| iNOS inhibition | LPS-stimulated macrophages, isolate | IC₅₀ 6.8 ± 0.1 µM 3Reference 3Phytochemical analysis of Cichorium bottae root and anti-inflammatory potential assessment of isolatesView study → |
| Acetylcholinesterase inhibition | In vitro enzyme assay, isolate | IC₅₀ 308.1 µM (CI₉₅ 243.9–405.3) 1Reference 1Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybusView study → |
| Anti-inflammatory reporter gene | scCO₂ chicory fraction | 53.4 ± 3.9% inhibition at 10 µg/mL 10Reference 10Supercritical CO₂ extraction as a tool to isolate anti-inflammatory sesquiterpene lactones from Cichorium intybus L. rootsView study → |
| Nematode egg-hatch inhibition | H. contortus, whole extract | EC₅₀ 2.6 mg/mL (DOL-rich extract) 7Reference 7In vitroIn vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg populationView study → |
| Acute liver injury | LPS/D-GalN mice, isolate | Protective; dose not extractable from the abstract 2Reference 2Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2View study → |
Because no pharmacokinetic study exists, none of these concentrations has been shown to be achievable in a living human, and the gap between the 6.8 µM and 308 µM figures spans the entire plausible-to-implausible range. These are doses and concentrations used in research and are not a personal recommendation.
References
- Rollinger JM, Mocka P, Zidorn C, Ellmerer EP, Langer T, Stuppner H (2005). Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus. Current Drug Discovery Technologies. https://pubmed.ncbi.nlm.nih.gov/16472227/
- Zhou Y, Wen T, Yang S, Meng B, Wei J, Zhang J, Wang L, Shen X (2025). Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/39904423/
- Elbermawi A, Zulfiqar F, Khan SI, Khan IA, Ali Z (2024). Phytochemical analysis of Cichorium bottae root and anti-inflammatory potential assessment of isolates. Fitoterapia. https://pubmed.ncbi.nlm.nih.gov/38945492/
- Cavin C, Delannoy M, Malnoe A, Debefve E, Touché A, Courtois D, Schilter B (2005). Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. Biochemical and Biophysical Research Communications. https://pubmed.ncbi.nlm.nih.gov/15649409/
- Valente AH, de Roode M, Ernst M, Peña-Espinoza M, Bornancin L, Bonde CS, Martínez-Valladares M, Ramünke S, Krücken J, Simonsen HT, Thamsborg SM, Williams AR (2021). Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionation. International Journal for Parasitology: Drugs and Drug Resistance. https://pubmed.ncbi.nlm.nih.gov/33618233/
- Peña-Espinoza M, Boas U, Williams AR, Thamsborg SM, Simonsen HT, Enemark HL (2015). Sesquiterpene lactone containing extracts from two cultivars of forage chicory (Cichorium intybus) show distinctive chemical profiles and in vitro activity against Ostertagia ostertagi. International Journal for Parasitology: Drugs and Drug Resistance. https://pubmed.ncbi.nlm.nih.gov/27120066/
- Foster JG, Cassida KA, Turner KE (2011). In vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg population. Veterinary Parasitology. https://pubmed.ncbi.nlm.nih.gov/21477927/
- Mares D, Romagnoli C, Tosi B, Andreotti E, Chillemi G, Poli F (2005). Chicory extracts from Cichorium intybus L. as potential antifungals. Mycopathologia. https://pubmed.ncbi.nlm.nih.gov/16160773/
- Harmatha J, Zídek Z, Kmoníčková E (2024). Inhibitory effect of selected guaianolide and germacranolide sesquiterpene lactones on nitric oxide production. Molecules. https://pubmed.ncbi.nlm.nih.gov/39064869/
- Baixinho JP, Anastácio JD, Ivasiv V, Cankar K, Bosch D, Menezes R, de Roode M, Santos CND, Matias AA, Fernández N (2021). Supercritical CO₂ extraction as a tool to isolate anti-inflammatory sesquiterpene lactones from Cichorium intybus L. roots. Molecules. https://pubmed.ncbi.nlm.nih.gov/33925241/
- Cankar K, Hakkert JC, Sevenier R, Papastolopoulou C, Schipper B, Baixinho JP, Fernández N, Matos MS, Serra AT, Santos CN, Vahabi K, Tissier A, Bundock P, Bosch D (2023). Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.). Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/37036799/
- Cankar K, Hakkert JC, Sevenier R, Campo E, Schipper B, Papastolopoulou C, Vahabi K, Tissier A, Bundock P, Bosch D (2022). CRISPR/Cas9 targeted inactivation of the kauniolide synthase in chicory results in accumulation of costunolide and its conjugates in taproots. Frontiers in Plant Science. https://pubmed.ncbi.nlm.nih.gov/36105709/
- Bogdanović M, Cankar K, Dragićević M, Bouwmeester H, Beekwilder J, Simonović A, Todorović S (2020). Silencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus L. GM Crops & Food. https://pubmed.ncbi.nlm.nih.gov/31668117/
- de Kraker JW, Franssen MC, de Groot A, König WA, Bouwmeester HJ (1998). (+)-Germacrene A biosynthesis. The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiology. https://pubmed.ncbi.nlm.nih.gov/9701594/
- Chadwick M, Gawthrop F, Michelmore RW, Wagstaff C, Methven L (2016). Perception of bitterness, sweetness and liking of different genotypes of lettuce. Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/26616925/
- Sessa RA, Bennett MH, Lewis MJ, Mansfield JW, Beale MH (2000). Metabolite profiling of sesquiterpene lactones from Lactuca species. Major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/10858433/
- García CJ, Beltrán D, Tomás-Barberán FA (2020). Human gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo. Molecular Nutrition & Food Research. https://pubmed.ncbi.nlm.nih.gov/32970341/
- Malarz J, Stojakowska A, Kisiel W (2013). Long-term cultured hairy roots of chicory — a rich source of hydroxycinnamates and 8-deoxylactucin glucoside. Applied Biochemistry and Biotechnology. https://pubmed.ncbi.nlm.nih.gov/23975347/
- Wesołowska A, Nikiforuk A, Michalska K, Kisiel W, Chojnacka-Wójcik E (2006). Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/16621374/
- Scioli G, Pin L, Testone G, Sobolev AP, Giannino D (2026). Metabolic profiling of sugarloaf chicory roots: structural assignment of sesquiterpene lactone conjugates and response to reduced irrigation. Molecules. https://pubmed.ncbi.nlm.nih.gov/41752490/
- Dai W, Lv Y, Quan M, Ma M, Shang Q, Yu G (2024). Bacteroides salyersiae is a candidate probiotic species with potential anti-colitis properties in the human colon: first evidence from an in vivo mouse model. Nutrients. https://pubmed.ncbi.nlm.nih.gov/39275234/
- Paulsen E, Andersen KE, Hausen BM (2001). Sensitization and cross-reaction patterns in Danish Compositae-allergic patients. Contact Dermatitis. https://pubmed.ncbi.nlm.nih.gov/11683829/
- Retraction (2021). Retracted: antitumor effects of 8-deoxylactucin in RB355 human retinoblastoma cells are mediated via apoptosis induction, reactive oxygen species production, and cell cycle arrest. Medical Science Monitor. https://pubmed.ncbi.nlm.nih.gov/33762557/
